Cervical cancer is one of the most preventable yet still highly prevalent cancers affecting Filipino women. Every day, 12 Filipinas die from this disease — a number that is deeply concerning, especially given that many of these cases are linked to the Human Papillomavirus (HPV), a common and preventable infection. With more access to effective vaccines, timely health education, and public-private partnerships, we can dramatically reduce the burden of cervical cancer in the Philippines. At the heart of this effort is the HPV vaccination — a critical shield against not just cervical cancer, but other HPV-related diseases as well.
What is HPV and Why Is It Dangerous?
HPV is a group of more than 100 related viruses, with over 40 of them transmitted through sexual contact. While many infections are harmless and resolve on their own, some strains — particularly HPV types 16 and 18 — are responsible for approximately 70% of cervical cancer cases globally. HPV is also linked to other diseases such as genital warts and cancers of the anus, penis, throat, and vulva.
Because HPV infections often show no symptoms, many people are unaware they have it until complications appear — making prevention through vaccination all the more essential.
DOH Omnibus Guidelines: Who Should Get the HPV Vaccine?
The Philippine Department of Health (DOH) recognizes the significance of HPV vaccination in the fight against cervical cancer. As outlined in the DOH Omnibus Health Guidelines for the Implementation of HPV Vaccination, the vaccine is recommended for:
Girls and women aged 9 to 45 years old
Boys and men aged 9 to 26 years old
However, the DOH’s public immunization program currently focuses on girls aged 9 to 14, a critical age group before the initiation of sexual activity, when the vaccine is most effective. The vaccine is given for free in public schools and health centers, following the global recommendations of the World Health Organization.
The Gaps in Coverage: Who Takes Care of the Others?
While the public sector is doing its part by offering free HPV vaccinations to 9–14-year-old girls, there is a growing concern: what about those in the private sector?
Many young girls who are not enrolled in public schools or who rely on private healthcare systems may miss out on the free vaccination initiative. Additionally, what happens to the women aged 15 and beyond — up to age 45 — who are also eligible for vaccination? In most cases, they must turn to out-of-pocket payment or private insurance, both of which may be financially burdensome.
This disparity raises important questions about equity in healthcare access and underscores the need for expanded vaccination efforts beyond the public school system.
A Proactive Model: Dynamic Business Outsourcing Solutions Leads the Way
Fortunately, there are pioneering organizations stepping up to fill this gap. One standout example is Dynamic Business Outsourcing Solutions (DBOS), a Philippine-based BPO company that recognizes the value of investing in their employees’ long-term health.
Understanding the critical role of HPV vaccination in protecting women from cervical cancer, DBOS launched an internal vaccination program for its female employees. To make the initiative feasible and cost-effective, DBOS purchased the vaccines in bulk, significantly lowering the price per dose — a model that could easily be adopted by other companies.

To implement this life-saving program, DBOS partnered with End Cervical Cancer Philippines, Inc., a nonprofit organization committed to raising awareness, advocating for better policies, and improving access to cervical cancer prevention tools such as HPV vaccines and screening. Through this collaboration, DBOS employees received educational sessions and access to affordable HPV vaccinations — an investment not just in employee well-being, but in workplace productivity and sustainability.
Support for DOLE’s Workplace Health Advocacy
This initiative also echoes the Department of Labor and Employment (DOLE)‘s advocacy for integrating cervical cancer and HPV awareness programs in the workplace. In recent years, DOLE has issued memoranda urging companies to create healthier, more informed work environments, recognizing that preventive health measures are an essential part of employee welfare.


By acting on this call, DBOS has set an example of what’s possible when the private sector collaborates with public health advocates. It shows that corporations can go beyond compliance — they can be active contributors to public health.
Why the HPV Vaccine Matters — Now More Than Ever
The benefits of HPV vaccination are clear:
It prevents up to 90% of cervical cancers when administered before exposure to the virus.
It reduces the burden of healthcare costs associated with cancer treatment.
It supports gender equity in health, as men can also carry and transmit the virus, and in rare cases, develop related cancers themselves.
It opens up conversations about sexual health, cancer prevention, and the role of both public and private sectors in building healthier communities.
Despite these advantages, vaccine hesitancy, misinformation, and lack of access still hinder uptake in many parts of the country.
A Call to Action
If we are to meet the World Health Organization’s goal of eliminating cervical cancer as a public health problem, the Philippines must address the gaps in vaccine access, particularly among girls in the private school system and women aged 15 to 45 who may not be covered by public programs.
We need to:
Expand public awareness campaigns so parents and women understand the safety and benefits of HPV vaccination.
Encourage companies to take part in employee health initiatives, like DBOS has done.
Urge the government to create subsidy programs or incentives for private sector vaccination access.
Support NGOs and advocacy groups like End Cervical Cancer Philippines Inc. that work on the frontlines to educate and vaccinate.
Final Thoughts
Cervical cancer is one of the few cancers we can truly prevent — and HPV vaccination is the key. While the government has laid the groundwork by offering free vaccines to young girls in public schools, it’s time to bridge the gap for those left behind: the girls in the private sector and women in their 20s, 30s, and 40s.
The model established by DBOS, in partnership with End Cervical Cancer Philippines Inc., proves that workplace-based vaccination programs are both practical and impactful. It’s a call for other organizations to follow suit — because health is not just a personal responsibility; it’s a shared one.
Together, we can build a future where cervical cancer is no longer a death sentence — but a disease of the past.

